Stress and Resilience in Anesthesia Professionals

Resilience Clinical Trial

— ResiStress  

Official title:

Stress and Resilience in Anesthesia Professionals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05073445
• Other study ID #: IRB 02021 - 097
• Status: Completed
• Start date: June 18, 2021
• Est. completion date: November 15, 2021

Study information

• Verified date: March 2022
• Source: University Hospital, Grenoble
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study was to analyze the correlation between the resilience of anesthesia professionals and the stress measured during a simulation session.

Description:

This trial will be carried out at the simulation center of the training institute for health professionals of the CHU Grenoble Alpes. Volunteer anesthesia professionals and students will perform a scenario simulating a pediatric laryngospasm during a surgical incision.

Each scenario will be performed by a medical and paramedical anesthesia pair and supervised by simulation trainers.

Stress and resilience measures will be taken at various times during the study. Participants will be debriefed at the end of the simulation.

The primary objective is to analyze the correlation between anesthesia professionals' resilience and measured stress.Secondary objectives are to study the association between: SDNN-measured stress and VAS-reported stress, age and SDNN-measured stress, CD RISC 10 resilience and PSS10-reported stress, CD RISC resilience and VAS-reported stress, the effect of experience on SDNN-measured stress, multiple correlation of the different secondary criteria.

secondary criteria.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: November 15, 2021
• Est. primary completion date: October 13, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• volunteer in anesthesia

Exclusion Criteria:

• Rhythm disorders

• Endocrine pathology

• High blood pressure

• Pregnancy or breastfeeding in progress

• Taking anti-inflammatory or psychotropic drugs that interfere with the heart rate

• Interruption of professional practice in anesthesia > 2 years

Related Conditions & MeSH terms

• Anaesthesiology
• High Fidelity Simulation
• Occupational Stress
• Resilience
• Stress, Professional

Intervention

Behavioral:
• SDNN measurement
SDNN measurement during pediatric simulation

Locations

Country	Name	City	State
France	University Hospital	Grenoble

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during the laryngospasm (during 3 minutes at 6 minutes)
Primary	Resilience	Measurement of resilience by Connor-Davidson Resilience Scale 10 (CD RISC 10 from 0 to 40) in participants. A high score indicates better resilience.	5 days before scenario
Secondary	Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	5 days before scenario
Secondary	Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just Before the scenario (at 0 minute )
Secondary	Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just after briefing (at 3 minutes)
Secondary	Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just after the end of scenario (at 9 minutes)
Secondary	Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just after the debriefing (at 30 minutes)
Secondary	Perceived Stress Scale	The Perceived Stress Scale (PSS10 from 10 To 50) measures the degree to which respondents feel their lives are unpredictable, uncontrollable, and overloaded. A high score indicates more stress.	5 days before scenario
Secondary	Age of anesthesia professionals	Age of anesthesia professionals: (quantitative variable)	5 days before scenario
Secondary	Experience in anesthesia:	Experience in anesthesia: number of years since the beginning of specialized training training (quantitative variable)	5 days before scenario
Secondary	Pediatric experience:	Pediatric experience: qualitative variable (yes, no)	5 days before scenario
Secondary	Pediatric laryngospasm experience	Pediatric laryngospasm experience: qualitative variable: (yes, no)	5 days before scenario
Secondary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	5 days before scenario (during 3 minutes)
Secondary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	Before the scenario (during 3 minutes)
Secondary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during briefing (during 3 minutes at 0 minutes)
Secondary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during the scenario before the laryngospasm (during 3 minutes at 3 minutes)
Secondary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during the debriefing (3 minutes at 9 minutes)
Secondary	Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	after the debriefing (3 minutes at 30 minutes)